共 67 条
- [52] Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing [J]. PLOS ONE, 2017, 12 (08):
- [55] Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds [J]. MOLECULAR THERAPY-ONCOLYTICS, 2019, 13 : 93 - 106
- [56] A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys [J]. SCIENTIFIC REPORTS, 2015, 5
- [58] Modeling Oncolytic Viral Therapy, Immune Checkpoint Inhibition, and the Complex Dynamics of Innate and Adaptive Immunity in Glioblastoma Treatment [J]. FRONTIERS IN PHYSIOLOGY, 2020, 11